Koers Hadasit Bio Holding Ltd. TEL AVIV STOCK EXCHANGE
Aandelen
IL0010954050
Biotechnologie & Medisch Onderzoek
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 7,43 mln. 1,97 mln. 743 mln. 1,84 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -31 mln. -8,23 mln. -3,1 mld. -7,66 mln. | Nettowinst (verlies) 2023 | -29 mln. -7,7 mln. -2,9 mld. -7,16 mln. | EV/omzet 2022 | - |
Nettoliquiditeiten 2022 | 12,93 mln. 3,43 mln. 1,29 mld. 3,19 mln. | Nettoliquiditeiten 2023 | 6,46 mln. 1,72 mln. 646 mln. 1,6 mln. | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-0,46
x | K/w-verhouding 2023 |
-0,25
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 25% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Yoram Azulai
CEO | Chief Executive Officer | 63 | 20-09-15 |
Tamar Raz
CHM | Chairman | 61 | 18-05-14 |
Doron Cohen
AUD | Comptroller/Controller/Auditor | 53 | 31-08-15 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Doron Nevo
BRD | Director/Board Member | 68 | 29-07-18 |
Erez Meltzer
BRD | Director/Board Member | 67 | 05-07-16 |
Orit Stav
BRD | Director/Board Member | 53 | 01-11-17 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+19,41% | 45,51 mld. | |
-8,62% | 38,52 mld. | |
+38,65% | 38,13 mld. | |
+26,95% | 30,74 mld. | |
-13,50% | 26,03 mld. | |
+10,74% | 25,92 mld. | |
+44,87% | 14,13 mld. | |
+34,36% | 12,73 mld. | |
-7,14% | 11,29 mld. |